PLRZ - CONSENSUS CO - Polyrizon Ltd

Polyrizon Ltd (PLRZ) is attracting biotechnologists to create innovative nasal sprays by offering them a state-of-the-art laboratory infrastructure. The company relies on a team of biochemists developing hydrogel viral barriers, which are retained by an RSU system. The current metric stands at 0.00. This daily price chart illustrates the asset's dynamics, the success of which is tied to biopolymer trials amid stable liquidity levels.

This indicator aggregates average price targets from professional analysts, filtering out market noise to identify the asset's fundamental value. The market consensus forecast vector reflects expert expectations regarding the capitalization of Polyrizon Ltd (PLRZ) amid the commercial launch of nasal gels and the expansion of its customer base, allowing investors to compare the actual market price with the business's calculated growth potential.